Svetlana Lucas – Biography
Last update: January 22, 2026Executive profile
Svetlana was Senior Vice President, Business Development at Tizona Therapeutics, and Head of Oncology and Inflammation at Amgen. Svetlana Lucas joined aTyr Pharma in 2024.
Svetlana Lucas is currentlyChief Business Officer at Scribe Therapeutics - View - Scribe Therapeutics org chart
Director at Jasper Therapeutics - View - Jasper Therapeutics org chart
Director at aTyr Pharma - View - aTyr Pharma org chart
Create your alert
to follow the career of Svetlana Lucas.
Education
Svetlana Lucas has a Bachelor in Biology from Lomonosov Moscow State University and a PhD in Molecular Biology and Biochemistry from California Institute of Technology.
They have also studied at Lomonosov Moscow State University :
Find more alumni from Lomonosov Moscow State University
They have also studied at California Institute of Technology :
Find more alumni from California Institute of Technology
More about Svetlana Lucas
Selected links
Do you need to know more about Svetlana Lucas? More results.
Participate
Social media
- Svetlana Lucas on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Svetlana Lucas
The colleagues of Svetlana Lucas
Company Colleagues
- At Scribe Therapeutics, Svetlana Lucas has 20 colleagues including Benjamin Oakes (CEO & Director), Behzad Aghazadeh (Director)…
- At Jasper Therapeutics, Svetlana Lucas has 18 colleagues including Jeet Mahal (CEO & President), Judith Shizuru (Director)…
- At aTyr Pharma, Svetlana Lucas has 21 colleagues including Sanjay Shukla (CEO & Director), Timothy Coughlin (Chairman of the Board)…
Industry Colleagues
- In the Pharmaceuticals industry, Svetlana Lucas has 22,991 colleagues in 1,914 companies located in 68 countries. 10,821 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Svetlana Lucas.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Svetlana Lucas.
